Can a phone call save lives after sepsis? new trial in africa aims to find out

NCT ID NCT07407868

Recruiting now Disease control Sponsor: Makerere University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This study tests two ways to follow up with adult patients who survived sepsis in the hospital. One group gets enhanced discharge instructions, and the other gets those instructions plus automated phone calls checking on symptoms and providing health tips. The goal is to see if these strategies reduce deaths within 90 days after leaving the hospital. About 1,410 patients from Uganda, Nigeria, Ghana, and Mozambique will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Interactive Voice Response system (phone call system) plus enhanced discharge instructions
What this could lead to: If successful, this could show that simple phone-based follow-up after hospital discharge reduces deaths in sepsis survivors in low-resource settings.
What could go wrong: This is an early-stage trial testing a behavioral intervention, not a drug. Results may not apply broadly, and phone-based follow-up may not work in all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS

Contacts and locations

Locations

Masaka Regional Referral Hospital
RECRUITING

Masaka, Uganda
Mulago National Specialised Referral Hospital
NOT_YET_RECRUITING

Kampala, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.